WIM
BHVN icon

Westside Investment Management’s Biohaven BHVN Stock Holding History

Westside Investment Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23
Closed -$260 – 1480
2025
Q4 		$260 Buy
+23
New +$285 ﹤0.01% 1460

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $242M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Westside Investment Management's BHVN Position: Q1 2026 in Review

Westside Investment Management sold out of Biohaven (BHVN) in Q1 2026, closing a stake of 23 shares — an estimated $260 sold.

Westside Investment Management first reported a position in BHVN in Q4 2025 and held it in 1 quarter. The position peaked at $260 in Q4 2025. 276 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • Westside Investment Management reported no remaining Biohaven position as of Q1 2026 after selling out during the quarter.
  • Westside Investment Management sold 23 Biohaven shares in Q1 2026, an estimated $260.
  • Westside Investment Management first reported a position in Biohaven in Q4 2025 and held it in 1 quarter.
  • Westside Investment Management's Biohaven position peaked at $260 in Q4 2025.
  • 276 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Westside Investment Management's 13F filing for Q1 2026, filed 4 May 2026.